The DRC authorities have approved clinical trials for four experimental Ebola treatments, although the fatal disease outbreaks of newborn children…
The DRC authorities have approved clinical trials for four experimental Ebola treatments, although the fatal disease outbreaks of newborn children give rise to new fears.
DRC Health Ministry on Saturday said the clinical trials will enable researchers to gather valuable data in a country struggling for its worst outbreak of hemorrhagic fever.
“Precious information on the efficacy of the treatments obtained during the clinical trial allows the development of these treatments on a larger scale to save more lives,” the Ministry said.
The four treatments are mAb1
14, developed by the US government. ZMapp, an intravenous treatment made by Mapp Biopharmaceutical; Remdesivir made by Gilead Sciences; and Regeneron REGN-EB3.
The latest figures say that 151 patients received one of the four drugs. Of the 76 recycled, 44 died and 31 are still filed – a mortality rate of 37 percent.
On the other hand, mortality was approximately 80 percent among those who had not received treatment.
Despite the use of the treatments, as well as an experimental vaccine manufactured by Merck, the authorities have fought to contain the outbreak in the east of the country in the midst of widespread violent crime and community resistance to health workers.
Earlier this month, the Ebola detention operations were briefly paced after seven UN peacekeepers and 12 DRC soldiers were killed .
|WHO has reached mothers to address the Ebola eruption crisis [WHO/Junior Kannah/Handout via Reuters]|
Meanwhile, the World Health Organization (WHO) has warned that the disease has also infected children, a population group that is usually not known to catch the ebola.
In an update published this week, WHO reported 36 new confirmed cases of Ebola, including seven in newborn infants and infants younger than two. Six cases were reported in children between the ages of 2 and 17; One case was in a pregnant woman.
Although Ebola typically infects adults, as they are most likely to be exposed to the fatal virus, in some cases, children have been known to catch the disease when acting as caregivers.
Few cases of Ebola in infants have been reported, but experts suspect that transmission may occur through breast milk or close contact with infected parents.
Ebola is typically spread by contaminated body fluids. WHO cited health centers as a source of Ebola transmission, which calls the current epidemic “complicated and challenging.”
At least 228 people are believed to have died, and the WHO said last week that it expects the outbreak to be at least another six months.
The increasing number of cases in children and health workers – 39 healthcare workers have so far been infected – suggests that outbreaks have major problems with stopping the virus.
WHO said the risk of outbreaks spreading to neighboring countries is “very high” but it does not recommend restriction restrictions.
Uganda, this month, began to vaccinate health workers against Ebola in a heavy-traffled border area near the outbreak.